You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Relapsed%20T%20cell%20Non-Hodgkin%20Lymphoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Boston (CD79b-19 CAR T cells,

Not yet recruiting
  • Non-hodgkin Lymphoma
  • +9 more
  • CD79b-19 CAR T cells
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 6, 2023

B-Cell Non Hodgkin Lymphoma, B-Cell Acute Lymphoblastic Leukemia Trial in Hanoi (anti-CD19 CAR T-cells)

Recruiting
  • B-Cell Non Hodgkin Lymphoma
  • B-Cell Acute Lymphoblastic Leukemia
  • anti-CD19 CAR T-cells
  • Hanoi, Vietnam
    Vinmec Research Institute of Stem Cell and Gene Technology
Sep 5, 2023

Relapsed or Refractory B-cell Non-Hodgkin Lymphoma Trial in Suzhou (Obinutuzumab, Zanubrutinib, Lenalidomide)

Enrolling by invitation
  • Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
  • Suzhou, Jiangsu, China
    the First Affiliated Hospital of Soochow University
Mar 22, 2023

DLBCL - Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Follicular Lymphoma Trial (Bridging radiation therapy,

Not yet recruiting
  • DLBCL - Diffuse Large B Cell Lymphoma
  • +6 more
  • Bridging radiation therapy
  • +2 more
  • (no location specified)
Jan 4, 2023

Relapsed or Refractory B Cell Non-Hodgkin Lymphoma Trial (C-CAR066)

Not yet recruiting
  • Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
  • (no location specified)
Mar 23, 2023

Acute Lymphoblastic Leukemia, in Relapse, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in Columbus

Not yet recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • +5 more
  • CD19 specific Chimeric Antigen Receptor T Cell
  • Columbus, Ohio
    Nationwide Children's Hospital
Mar 9, 2023

Leukemia, Acute Lymphoblastic, Lymphoma, Non-Hodgkin Trial in Ribeirao Preto (CART-19)

Not yet recruiting
  • Leukemia, Acute Lymphoblastic
  • Lymphoma, Non-Hodgkin
  • CART-19
  • Ribeirao Preto, Sao Paulo, Brazil
    Ribeirao Preto School of Medicine, University of Sao Paulo
Oct 23, 2023

Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma Trial in Tianjin (CD19-targeted Chimeric Antigen Receptor(CAR) T Cells)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Diffuse Large B Cell Lymphoma
  • CD19-targeted Chimeric Antigen Receptor(CAR) T Cells
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital
Nov 19, 2023

B-cell Non Hodgkin Lymphoma Trial (Odronextamab, Loncastuximab tesirine, Rituximab)

Not yet recruiting
  • B-cell Non Hodgkin Lymphoma
  • (no location specified)
Aug 7, 2023

LY007 for r/r B-NHL and Exploration of Novel CAR-T Translational

Not yet recruiting
  • Relapsed Non-Hodgkin Lymphoma
    • (no location specified)
    Sep 19, 2023

    Lymphoma, Non-Hodgkin Trial (JNJ-87801493, JNJ-80948543, JNJ-75348780)

    Not yet recruiting
    • Lymphoma, Non-Hodgkin
    • (no location specified)
    Nov 15, 2023

    B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

    Not yet recruiting
    • B-cell Non Hodgkin Lymphoma
    • Chronic Lymphocytic Leukemia
    • Cyclophosphamide injection
    • +2 more
    • Charleston, South Carolina
      Hollings Cancer Center at Medical University of South Carolina
    Jan 18, 2023

    Relapsed or Refractory Mantle Cell Lymphoma (MCL) Trial in Duarte (BAFFR-CAR T cells)

    Recruiting
    • Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
    • BAFFR-CAR T cells
    • Duarte, California
      City of Hope Medical Center
    Oct 18, 2022

    T-cell Non-Hodgkin's Lymphoma Trial (CD147- CAR T cells)

    Not yet recruiting
    • T-cell Non-Hodgkin's Lymphoma
    • CD147- CAR T cells
    • (no location specified)
    Aug 1, 2022

    T-cell Lymphoma, Cutaneous/Peripheral T-Cell Lymphoma, Peripheral T-cell Lymphoma Trial in Chicago (Fenretinide)

    Not yet recruiting
    • T-cell Lymphoma
    • +10 more
    • Chicago, Illinois
      Rush University Medical Center
    Oct 24, 2022

    CAR, B Cell Lymphoma, Relapsed Non-Hodgkin Lymphoma Trial in Suzhou (ThisCART19A with Dose Level 1, ThisCART19A with Dose Level

    Recruiting
    • CAR
    • +2 more
    • ThisCART19A with Dose Level 1
    • ThisCART19A with Dose Level 2
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Jan 18, 2023

    Lymphoma, Non-Hodgkin Lymphoma, B-Cell Trial (BAFF CAR-T)

    Not yet recruiting
    • Lymphoma, Non-Hodgkin Lymphoma, B-Cell
    • BAFF CAR-T
    • (no location specified)
    Aug 16, 2022

    Non Hodgkin Lymphoma Trial in Aurora (UCD19 CAR T Cells)

    Active, not recruiting
    • Non Hodgkin Lymphoma
    • UCD19 CAR T Cells
    • Aurora, Colorado
      University of Colorado Hospital
    Sep 1, 2022

    Non Hodgkin's Lymphoma Trial in Beijing (TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T),

    Not yet recruiting
    • Non Hodgkin's Lymphoma
    • TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T)
    • +2 more
    • Beijing, China
    • +2 more
    Aug 23, 2023

    B Cell Non-Hodgkin's Lymphoma Trial in Duarte (CD19/CD20-directed CAR-T cells)

    Recruiting
    • B Cell Non-Hodgkin's Lymphoma
    • CD19/CD20-directed CAR-T cells
    • Duarte, California
      City of Hope Medical Center
    Aug 10, 2022

    Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (Pirtobrutinib, LV20.19 CAR T cells)

    Not yet recruiting
    • Non Hodgkin Lymphoma
    • +5 more
    • (no location specified)
    Aug 4, 2023

    Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma Trial in United States (CB-010,

    Recruiting
    • Lymphoma, Non-Hodgkin
    • +6 more
    • CB-010
    • +2 more
    • Scottsdale, Arizona
    • +7 more
    Aug 19, 2022

    Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia Trial in Cleveland (Fully human anti CD19 CAR-T

    Recruiting
    • Non Hodgkin Lymphoma
    • +2 more
    • Fully human anti CD19 CAR-T Cell Dose
    • +2 more
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Oct 4, 2022

    Non-hodgkin Lymphoma,B Cell Trial in Beijing (Autologous CD19-STAR-T cell, Fludarabine, Cyclophosphamide)

    Recruiting
    • Non-hodgkin Lymphoma,B Cell
    • Autologous CD19-STAR-T cell
    • +2 more
    • Beijing, Beijing, China
    • +1 more
    Nov 21, 2022

    Recurrent Anaplastic Large Cell Lymphoma, Recurrent Angioimmunoblastic T-Cell Lymphoma, Recurrent Mature T- and NK-Cell

    Active, not recruiting
    • Recurrent Anaplastic Large Cell Lymphoma
    • +10 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 30, 2023